Recent news on Navelbine

Carbon OKs action over prescriptions  -  25 May 2007
Allentown Morning Call,Also included are Myleran, used to treat forms of blood cancer; Navelbine, for treating cancer, specifically some lung cancers; Retrovir, for treating HIV

Neoadjuvant Taxotere®, Navelbine®, and Herceptin® Active for ...  -  May 3, 2007
Cancer Consultants (press release),To evaluate patient outcomes after neoadjuvant treatment with Taxotere, Navelbine, and Herceptin, researchers conducted a Phase II clinical trial among 31

Neoadjuvant treatment for breast cancer  -  May 9, 2007
TopCancerNews.com,It stated that neoadjuvant treatment with Taxotere, Navelbine, and Herceptin resulted in a complete disappearance of detectable cancer in 39 percent of

Cross-Country: Their turn to serve society  -  May 12, 2007
New Straits Times,Recently approved by the Ministry of Health, the Navelbine Oral is meant to reduce the spread of cancer cells and relieve painful symptoms caused by the

ADVENTRX Pharmaceuticals Reports First Quarter 2007 Financial Results  -  May 7, 2007
PR Newswire (press release),The Company expects to complete the study in 2007 and, if it demonstrates bioequivalence with the currently marketed product, Navelbine(R) (vinorelbine

Neoadjuvant Taxotere®, Navelbine® and Herceptin® Active for ...  -  Apr 4, 2007
Cancer Consultants (press release),Researchers involved in a multicenter trial have reported that a regimen of Taxotere (docetaxel), Navelbine (venorelbine) and Herceptin® produces a 39%

Certain genes make chemotherapy drugs more potent at lower doses  -  Apr 16, 2007
TopCancerNews.com,Two other drugs -- Navelbine and Gemzar -- were tested on six of the Taxol-sensitive genes. The genes did not respond to these drugs.

Study uncovers genes which affect chemotherapy impact  -  Apr 13, 2007
Cancer Research UK - News & Resources,Postdoctoral researcher Dr Angelique Whitehurst explained that tests involving other chemotherapy drugs, vinorelbine (Navelbine) and gemcitabine (Gemzar),

Scientists discover chemotherapy sensitive genes  -  Apr 12, 2007
Pharmaceutical Business ReviewThe researchers re-tested six genes that showed the most dramatic effect with Taxol and tried the same test using the chemotherapy drugs Navelbine and

Genes May Boost Lung Cancer Chemo  -  Apr 11, 2007
WebMDWhite's team also tested six Taxol-sensitive genes with two other chemotherapy drugs, Navelbine and Gemzar. The Taxol-sensitive genes weren't very sensitive

Massive Gene Screening Points Way To More Effective Chemotherapy  -  Apr 15, 2007
Medical News Today (press release),...test using the chemotherapy drugs vinorelbine (Navelbine) and gemcitabine (Gemzar), but the results were not as dramatic as those seen for paclitaxel.

New Breast Cancer Drug Combination Proves More Effective  -  Mar 16, 2007
TopCancerNews.com,One group of women was treated with Gemzar (gemcitabine) and Navelbine (vinorelbine), the other group was treated with Navelbine alone.

Chemotherapy Resistance Testing in Lung Cancer Patients Needs to ...  -  Mar 17, 2007
eMaxHealth.com,...of tumors to carboplatin-paclitaxel, 24 percent to cisplatin-navelbine, 42 percent to cisplatin-gemcitabine and 27 percent to cisplatin-docetaxel.

Addition of Gemzar® to Navelbine® Improves Progression-free ...  -  Feb 16, 2007
Cancer Consultants (press release),According to an article recently published in Lancet Oncology, the addition of the chemotherapy agent Gemzar® (gemcitabine) to Navelbine® (vinorelbine)

Gene profiling predicts resistance to breast cancer drug Herceptin  -  Feb 22, 2007
innovations report,They then treated the women with a combination of Herceptin and the chemotherapy drug Navelbine weekly for 12 weeks. Although this is not the first study to

ADVENTRX Cleared To Initiate Vinorelbine Emulsion Bioequivalence Study  -  Dec 29, 2006
Medical News Today (press release),The study is a multicenter, open-label, randomized crossover comparison of ANX-530 and the approved reference product Navelbine(R) (vinorelbine tartrate) in

ADVENTRX Cleared to Initiate Vinorelbine Emulsion Bioequivalence Study  -  Dec 26, 2006
PR Newswire (press release),Navelbine is an anti-cancer agent approved for use in non-small cell lung cancer. Patient recruitment for this study is expected to begin in January 2007.

Market Report -- In Play (ANX)  -  Dec 26, 2006
MSN MoneyIn taking this action, the FDA acknowledged the suitability of the co's clinical study protocol to establish the bioequivalence of ANX-530, and Navelbine.

StreetInsider.com Pre-Open Movers 12/26  -  Dec 26, 2006
StreetInsider.com (subscription),Navelbine is an anti-cancer agent approved for use in non-small cell lung cancer. Fuwei Films Co., Ltd. (Nasdaq: FFHL) 13% HIGHER; last week's IPO extends

Tuesday's Small-Cap Winners & Losers  -  Dec 26, 2006
TheStreet.com...proposed cancer drug ANX-530, deeming it to be bioequivalent to Navelbine, an existing cancer treatment approved for use in nonsmall cell lung cancer.

Adventrx to begin trials on cancer drug  -  Dec 26, 2006
BusinessWeekThe drug maker will conduct trials to establish that its drug, ANX-530, works the same as Navelbine, an anti-cancer agent approved to fight non-small cell

Adventrx to initiate trials of potential cancer drug  -  Dec 27, 2006
newratings.com...trials to show that its ANX-530 drug works in the same manner as an existing anti-cancer agent, Navelbine, approved to fight non-small cell lung cancer.

Re-Induction Chemotherapy May Improve Survival for Some Patients ...  -  Jan 2, 2007
Cancer Consultants (press release),This trial included 48 patients who were all initially treated with 6 courses of PEV (Platinol® (cisplatin), Ellence® (epirubicin), Navelbine® (vinorelbine)

Short-term T-bill rates up  -  Dec 27, 2006
San Diego Union Tribune,The San Diego drug development company said it would conduct clinical trials to establish that its drug, ANX-530, works the same as Navelbine,

ADVENTRX Cleared to Initiate Vinorelbine Emulsion Bioequivalence Study  -  26 Dec 2006
FinanzNachrichten.de,The study is a multicenter, open-label, randomized crossover comparison of ANX-530 and the approved reference product Navelbine(R) (vinorelbine tartrate) in

Additional Chemotherapy May Improve Survival for Some Patients ...  -  Dec 18, 2006
Cancer Consultants (press release),This trial included 48 patients who were all initially treated with the chemotherapy drugs Platinol® (cisplatin), Ellence® (epirubicin), and Navelbine®

Adjuvant Platinol®/Navelbine® Improves Survival in NSCLC  Oct 11, 2006
...the Late Adjuvant Cisplatin Evaluation (LACE vinorelbine project) have reported that adjuvant Platinol® (cisplatin) plus Navelbine® (vinorelbine) improves ... -Cancer Consultants (press release), Platinol®/Navelbine® Improves Survival in Lung Cancer  Oct 9, 2006
...of the European Society for Medical Oncology (ESMO), the chemotherapy combination consisting of Platinol® (cisplatin) plus Navelbine® (vinorelbine) improves ... -Cancer Consultants (press release), Radiation Plus Chemo Doubles Survival Time After Lung Cancer ...  Nov 8, 2006
Herblain, France presented the findings of Adjuvant Navelbine-Cisplatin Chemotherapy versus Observation (ANITA 1), a randomized trial of 840 patients with ... -Cancerpage.com, Improved Progression-Free Survival in Advanced Breast Cancer with ...  Oct 13, 2006
...expressing HER-2. Herceptin is usually combined with chemotherapeutic agents such as Taxol® (paclitaxel), Taxotere® (docetaxel), and Navelbine® (vinorelbine ... -Cancer Consultants (press release), Tussentijdse bedrijfsinkomsten Kyowa Hakko 18,4 procent gestegen  Oct 29, 2006
...agent, were lower than in the first half of last fiscal year but sales of Durotep Patch, an analgesic for persistent cancer pain, and Navelbine, an anticancer ... -Netherlands Corporate News (persbericht), Diatos Strengthens Management Team with the Appointment of New ...  Oct 9, 2006
France) in a similar position with full responsibility for the corporate clinical development and implementation of Navelbine ® (vinorelbine) worldwide. ... -Business Wire (press release), Final Results of Adjuvant Chemotherapy Versus Observation for ...  Aug 28, 2006
Researchers affiliated with the Adjuvant Navelbine International Trialist Association (ANITA) have published the final results of a randomized trial evaluating ... -Cancer Consultants

Addition of Gemzar® to Paraplatin® Improves Progression-Free ...  Sep 20, 2006
...treatment of recurrent ovarian cancer including: Doxil® (pegylated doxorubicin), Thalomid® (thalidomide), Hycamptin® (topotecan) and Navelbine® (vinorelbine ... -Cancer Consultants

A mother's struggle  -  Nov 26, 2006
Dailyrecord.com,...a less potent version of the type of drug used in the clinical trial, and Navelbine, a less aggressive drug that had helped her in pregnancy.

Final Results of Adjuvant Chemotherapy Versus Observation for ...  29 Aug 2006
Researchers affiliated with the Adjuvant Navelbine International Trialist Association (ANITA) have published the final results of a randomized trial evaluating ... -Cancer Consultants

Navelbine®/Platinol® Improves Survival in Some Patients with ...  Aug 22, 2006
According to an early online publication in the Lancet Oncology, the chemotherapy combination consisting of Navelbine® (vinorelbine) and Platinol® (cisplatin ... -Cancer Consultants

Taxotere® plus Platinum Compounds Improves Quality of Life over ...  Aug 7, 2006
...published in Lung Cancer, the treatment combination including Taxotere® plus a platinum improves quality of life compared to Navelbine® plus platinum in ... -Cancer Consultants

Taxotere® (Docetaxel) May Be Superior to Navelbine® ...  Aug 2, 2006
...agent Taxotere provides superior progression-free survival and improves symptoms caused by cancer better than treatment with single-agent Navelbine for elderly ... -Cancer Consultants

Taxotere® May Be Superior to Navelbine® for Elderly with ...  Aug 1, 2006
...provides superior progression-free survival and improves symptoms caused by cancer better than treatment with single-agent Navelbine® (vinorelbine) for ... -Cancer Consultants

Adjuvant Chemotherapy May Improve NSCLC Survival  Aug 18, 2006
18 -- Adjuvant Navelbine (vinorelbine)-Platinol (cisplatin) improved overall survival in patients with stage IB to IIIA non-small cell lung cancer (NSCLC ... -MedPage Today

Taxotere® (Docetaxel)-Platinum Combinations Improve Quality of ...  Aug 4, 2006
...results in better quality of life (QOL) assessments in patients with advanced non-small cell lung cancer than the combination of Navelbine® (vinorelbine) and ... -Cancer Consultants

Breast Cancer Treatments' Links to Heart Disease Calculated  Aug 15, 2006
181.9 months. Sixty-three percent of the women had concomitant Navelbine (vinorelbine) and 84% received concomitant taxanes. In ... -MedPage Today

Non-Small-Cell Lung Cancer: Advances in the Treatment of Early and ...  Aug 2, 2006
...up. On behalf of the Adjuvant Navelbine International Trialist Association. Proc Am Soc Clin Oncol. 2005;23:624s. Abstract 7013. ... -Medscape (subscription)



Herceptin® May Change the Natural History of Patients with HER2 ...  May 1, 2006
Italian researchers have reported that patients with HER2-positive breast cancer treated with Herceptin (trastuzumab) and Navelbine® (vinorelbine) have better ... - Cancer Consultants

Additional Evidence that Herceptin® Benefits Women with HER2 ...  Apr 17, 2006
...a study conducted in Italy, women with metastatic HER2-positive breast cancer who were treated with Herceptin® (trastuzumab) and Navelbine® (vinorelbine) had ... - Cancer Consultants

Sequential Two-Drug Combinations Explored in Advanced NSCLC  Apr 20, 2006
...of a phase II clinical trial conducted in Greece, treatment of stage IIIB or stage IV non-small cell lung cancer (NSCLC) with Navelbine® (vinorelbine) and ... - Cancer Consultants

Hana Biosciences Completes Licensing of Three Targeted Cancer Drug ...  May 8, 2006
Vinorelbine (Navelbine(R); GlaxoSmithKline), a microtubule inhibitor, is approved for use as a single agent or in combination with cisplatin for the first ... - Genetic Engineering News

Kyowa Hakko Profits Decline on Higher R&D Spend but Recurring ...  Apr 27, 2006
Allelock, an antiallergic agent (olopatadine hydrochloride),Durotep Patch, an analgesic for persistent cancer pain, and Navelbine,an anticancer agent, each ... - Finanzen.net





Hana Biosciences to License Three Targeted Cancer Drug Candidates ...  Mar 17, 2006
Vinorelbine (Navelbine(R); GlaxoSmithKline), a microtubule inhibitor, is approved for use as a single agent or in combination with cisplatin for the first ... - Genetic Engineering News

Hana Paying Up To $42M For Inex’s Cancer Drugs  Mar 17, 2006
Vinorelbine, branded Navelbine by GlaxoSmithKline plc, of London, also is a microtubule inhibitor, approved for use as a single agent or in combination with ... - BioWorld Online (subscription)



Recurrence-Free Survival Improved with Taxotere® Compared to ...  Feb 23, 2006
...with the chemotherapy agent Taxotere® (docetaxel) improves recurrence-free survival compared with the chemotherapy agent Navelbine® (vinorelbine) for the ... - Cancer Consultants,

Information on knee pain, breast cancer drugs and protecting bones  Feb 22, 2006
The New England Journal of Medicine reports on a study comparing the drugs Taxotere and Navelbine in early breast cancer. A study ... - 7Online.com,

Breast meds limit recurrence  Feb 23, 2006
A new head-to-head study finds the chemotherapy drug docetaxel (Taxotere) beating another, vinorelbine (Navelbine), in helping extend patient survival after ... - Health24.com,

Nitroglycerin May Enhance Chemotherapy for Non-Small Cell Lung ...  Feb 6, 2006
Researchers from Japan have reported that the use of nitroglycerin combined with Navelbine® (vinorelbine) and Platinol® (cisplatin) may improve response ... - Cancer Consultants,

Nitroglycerin May Enhance Chemotherapy for Non-Small Cell Lung ...  Feb 6, 2006
Researchers from Japan have reported that the use of nitroglycerin combined with the chemotherapy drugs Navelbine® (vinorelbine) and Platinol® (cisplatin ... - Cancer Consultants,

Nitroglycerin May Enhance Chemotherapy for Non-Small Cell Lung ...  Feb 6, 2006
Researchers from Japan have reported that the use of nitroglycerin combined with Navelbine® (vinorelbine) and Platinol® (cisplatin) may improve response ... - Cancer Consultants

Nitroglycerin May Enhance Chemotherapy for Non-Small Cell Lung ...  Feb 6, 2006
Researchers from Japan have reported that the use of nitroglycerin combined with the chemotherapy drugs Navelbine® (vinorelbine) and Platinol® (cisplatin ... - Cancer Consultants

Innocent victims of a judgmental attitude  Feb 3, 2006
In certain centres a new drug, Navelbine (a form of vinorelbine), which can be taken by mouth, is now used in some forms of lung cancer almost immediately ... - Times Online

Kyowa Hakko Reports Good Progress Towards Full-Year Forecasts  Jan 30, 2006
Business, prescription pharmaceuticals Allelock, an antiallergic agent, Durotep Patch, an analgesic for persistent cancer pain, and Navelbine, an anticancer ... - Genetic Engineering News

Novel Strategies for Treating Lung Cancer: Chemotherapy  Jan 24, 2006
Institute of Canada) trial JBR-10, [12] which combined cisplatin and vinorelbine for stage IB and II, and ANITA (Adjuvant Navelbine International Trialists ... - Medscape (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional